Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice

Michèle Geoffrion, Xue-Liang Du, Zehra Irshad, Barbara C. Vanderhyden, Kerri Courville, Guangzhi Sui, Vivette D. D’Agati, Sylvie Ott-Braschi, Naila Rabbani, Paul J. Thornalley, Michael Brownlee, Ross W. Milne

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The reactive dicarbonyls, glyoxal and methylglyoxal (MG), increase in diabetes and may participate in the development of diabetic complications. Glyoxal and MG are detoxified by the sequential activities of glyoxalase 1 (GLO1) and glyoxalase 2. To determine the contribution of these dicarbonyls to the etiology of complications, we have genetically manipulated GLO1 levels in apolipoprotein E-null (Apoe−/−) mice. Male Apoe−/− mice, hemizygous for a human GLO1 transgene (GLO1TGApoe−/− mice) or male nontransgenic Apoe−/− litter mates were injected with streptozotocin or vehicle and 6 or 20 weeks later, aortic atherosclerosis was quantified. The GLO1 transgene lessened streptozotocin (STZ)-induced increases in immunoreactive hydroimidazolone (MG-H1). Compared to nondiabetic mice, STZ-treated GLO1TGApoe−/− and Apoe−/− mice had increased serum cholesterol and triglycerides and increased atherosclerosis at both times after diabetes induction. While the increased GLO1 activity in the GLO1TGApoe−/− mice failed to protect against diabetic atherosclerosis, it lessened glomerular mesangial expansion, prevented albuminuria and lowered renal levels of dicarbonyls and protein glycation adducts. Aortic atherosclerosis was also quantified in 22-week-old, male normoglycemic Glo1 knockdown mice on an Apoe−/− background (Glo1KDApoe−/− mice), an age at which Glo1KD mice exhibit albuminuria and renal pathology similar to that of diabetic mice. In spite of ~75% decrease in GLO1 activity and increased aortic MG-H1, the Glo1KDApoe−/− mice did not show increased atherosclerosis compared to age-matched Apoe−/− mice. Thus, manipulation of GLO1 activity does not affect the development of early aortic atherosclerosis in Apoe−/− mice but can dictate the onset of kidney disease independently of blood glucose levels.

Original languageEnglish (US)
Article numbere12043
JournalPhysiological Reports
Volume2
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Apolipoproteins E
Streptozocin
Atherosclerosis
Kidney
Pyruvaldehyde
Glyoxal
Albuminuria
Transgenes
Kidney Diseases
Diabetes Complications
Blood Glucose
Triglycerides
Cholesterol

Keywords

  • ApoE-deficient mice
  • Atherosclerosis
  • Diabetes
  • Glyoxalase
  • Nephropathy

ASJC Scopus subject areas

  • Physiology (medical)
  • Physiology

Cite this

Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice. / Geoffrion, Michèle; Du, Xue-Liang; Irshad, Zehra; Vanderhyden, Barbara C.; Courville, Kerri; Sui, Guangzhi; D’Agati, Vivette D.; Ott-Braschi, Sylvie; Rabbani, Naila; Thornalley, Paul J.; Brownlee, Michael; Milne, Ross W.

In: Physiological Reports, Vol. 2, No. 6, e12043, 2014.

Research output: Contribution to journalArticle

Geoffrion, M, Du, X-L, Irshad, Z, Vanderhyden, BC, Courville, K, Sui, G, D’Agati, VD, Ott-Braschi, S, Rabbani, N, Thornalley, PJ, Brownlee, M & Milne, RW 2014, 'Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice', Physiological Reports, vol. 2, no. 6, e12043. https://doi.org/10.14814/phy2.12043
Geoffrion, Michèle ; Du, Xue-Liang ; Irshad, Zehra ; Vanderhyden, Barbara C. ; Courville, Kerri ; Sui, Guangzhi ; D’Agati, Vivette D. ; Ott-Braschi, Sylvie ; Rabbani, Naila ; Thornalley, Paul J. ; Brownlee, Michael ; Milne, Ross W. / Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice. In: Physiological Reports. 2014 ; Vol. 2, No. 6.
@article{bf202589a0f84ff69260b95deac8f74c,
title = "Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice",
abstract = "The reactive dicarbonyls, glyoxal and methylglyoxal (MG), increase in diabetes and may participate in the development of diabetic complications. Glyoxal and MG are detoxified by the sequential activities of glyoxalase 1 (GLO1) and glyoxalase 2. To determine the contribution of these dicarbonyls to the etiology of complications, we have genetically manipulated GLO1 levels in apolipoprotein E-null (Apoe−/−) mice. Male Apoe−/− mice, hemizygous for a human GLO1 transgene (GLO1TGApoe−/− mice) or male nontransgenic Apoe−/− litter mates were injected with streptozotocin or vehicle and 6 or 20 weeks later, aortic atherosclerosis was quantified. The GLO1 transgene lessened streptozotocin (STZ)-induced increases in immunoreactive hydroimidazolone (MG-H1). Compared to nondiabetic mice, STZ-treated GLO1TGApoe−/− and Apoe−/− mice had increased serum cholesterol and triglycerides and increased atherosclerosis at both times after diabetes induction. While the increased GLO1 activity in the GLO1TGApoe−/− mice failed to protect against diabetic atherosclerosis, it lessened glomerular mesangial expansion, prevented albuminuria and lowered renal levels of dicarbonyls and protein glycation adducts. Aortic atherosclerosis was also quantified in 22-week-old, male normoglycemic Glo1 knockdown mice on an Apoe−/− background (Glo1KDApoe−/− mice), an age at which Glo1KD mice exhibit albuminuria and renal pathology similar to that of diabetic mice. In spite of ~75{\%} decrease in GLO1 activity and increased aortic MG-H1, the Glo1KDApoe−/− mice did not show increased atherosclerosis compared to age-matched Apoe−/− mice. Thus, manipulation of GLO1 activity does not affect the development of early aortic atherosclerosis in Apoe−/− mice but can dictate the onset of kidney disease independently of blood glucose levels.",
keywords = "ApoE-deficient mice, Atherosclerosis, Diabetes, Glyoxalase, Nephropathy",
author = "Mich{\`e}le Geoffrion and Xue-Liang Du and Zehra Irshad and Vanderhyden, {Barbara C.} and Kerri Courville and Guangzhi Sui and D’Agati, {Vivette D.} and Sylvie Ott-Braschi and Naila Rabbani and Thornalley, {Paul J.} and Michael Brownlee and Milne, {Ross W.}",
year = "2014",
doi = "10.14814/phy2.12043",
language = "English (US)",
volume = "2",
journal = "Physiological Reports",
issn = "2051-817X",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice

AU - Geoffrion, Michèle

AU - Du, Xue-Liang

AU - Irshad, Zehra

AU - Vanderhyden, Barbara C.

AU - Courville, Kerri

AU - Sui, Guangzhi

AU - D’Agati, Vivette D.

AU - Ott-Braschi, Sylvie

AU - Rabbani, Naila

AU - Thornalley, Paul J.

AU - Brownlee, Michael

AU - Milne, Ross W.

PY - 2014

Y1 - 2014

N2 - The reactive dicarbonyls, glyoxal and methylglyoxal (MG), increase in diabetes and may participate in the development of diabetic complications. Glyoxal and MG are detoxified by the sequential activities of glyoxalase 1 (GLO1) and glyoxalase 2. To determine the contribution of these dicarbonyls to the etiology of complications, we have genetically manipulated GLO1 levels in apolipoprotein E-null (Apoe−/−) mice. Male Apoe−/− mice, hemizygous for a human GLO1 transgene (GLO1TGApoe−/− mice) or male nontransgenic Apoe−/− litter mates were injected with streptozotocin or vehicle and 6 or 20 weeks later, aortic atherosclerosis was quantified. The GLO1 transgene lessened streptozotocin (STZ)-induced increases in immunoreactive hydroimidazolone (MG-H1). Compared to nondiabetic mice, STZ-treated GLO1TGApoe−/− and Apoe−/− mice had increased serum cholesterol and triglycerides and increased atherosclerosis at both times after diabetes induction. While the increased GLO1 activity in the GLO1TGApoe−/− mice failed to protect against diabetic atherosclerosis, it lessened glomerular mesangial expansion, prevented albuminuria and lowered renal levels of dicarbonyls and protein glycation adducts. Aortic atherosclerosis was also quantified in 22-week-old, male normoglycemic Glo1 knockdown mice on an Apoe−/− background (Glo1KDApoe−/− mice), an age at which Glo1KD mice exhibit albuminuria and renal pathology similar to that of diabetic mice. In spite of ~75% decrease in GLO1 activity and increased aortic MG-H1, the Glo1KDApoe−/− mice did not show increased atherosclerosis compared to age-matched Apoe−/− mice. Thus, manipulation of GLO1 activity does not affect the development of early aortic atherosclerosis in Apoe−/− mice but can dictate the onset of kidney disease independently of blood glucose levels.

AB - The reactive dicarbonyls, glyoxal and methylglyoxal (MG), increase in diabetes and may participate in the development of diabetic complications. Glyoxal and MG are detoxified by the sequential activities of glyoxalase 1 (GLO1) and glyoxalase 2. To determine the contribution of these dicarbonyls to the etiology of complications, we have genetically manipulated GLO1 levels in apolipoprotein E-null (Apoe−/−) mice. Male Apoe−/− mice, hemizygous for a human GLO1 transgene (GLO1TGApoe−/− mice) or male nontransgenic Apoe−/− litter mates were injected with streptozotocin or vehicle and 6 or 20 weeks later, aortic atherosclerosis was quantified. The GLO1 transgene lessened streptozotocin (STZ)-induced increases in immunoreactive hydroimidazolone (MG-H1). Compared to nondiabetic mice, STZ-treated GLO1TGApoe−/− and Apoe−/− mice had increased serum cholesterol and triglycerides and increased atherosclerosis at both times after diabetes induction. While the increased GLO1 activity in the GLO1TGApoe−/− mice failed to protect against diabetic atherosclerosis, it lessened glomerular mesangial expansion, prevented albuminuria and lowered renal levels of dicarbonyls and protein glycation adducts. Aortic atherosclerosis was also quantified in 22-week-old, male normoglycemic Glo1 knockdown mice on an Apoe−/− background (Glo1KDApoe−/− mice), an age at which Glo1KD mice exhibit albuminuria and renal pathology similar to that of diabetic mice. In spite of ~75% decrease in GLO1 activity and increased aortic MG-H1, the Glo1KDApoe−/− mice did not show increased atherosclerosis compared to age-matched Apoe−/− mice. Thus, manipulation of GLO1 activity does not affect the development of early aortic atherosclerosis in Apoe−/− mice but can dictate the onset of kidney disease independently of blood glucose levels.

KW - ApoE-deficient mice

KW - Atherosclerosis

KW - Diabetes

KW - Glyoxalase

KW - Nephropathy

UR - http://www.scopus.com/inward/record.url?scp=85003530455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85003530455&partnerID=8YFLogxK

U2 - 10.14814/phy2.12043

DO - 10.14814/phy2.12043

M3 - Article

VL - 2

JO - Physiological Reports

JF - Physiological Reports

SN - 2051-817X

IS - 6

M1 - e12043

ER -